Experimental disseminated aspergillosis in mice: Histopathological study

Journal de Mycologie Medicale

Volumn 18, Issue 2, 2008, Pages 75-82

  Mirkov, I ^a   Zolotarevski, L ^b   Glamoclija J ^a   Kataranovski, D ^a   Kataranovski, M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Animal model; Aspergillus fumigatus; Systemic response; Tissue histopathology

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONIDIUM; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; FUNGAL VIRULENCE; HISTOPATHOLOGY; LEUKOCYTE ADHERENCE; LEUKOCYTE AGGREGATION; LIVER; LUNG; LYMPHOCYTE COUNT; MORTALITY; MOUSE; NONHUMAN; SURVIVAL RATE; SURVIVAL TIME;

ANIMALIA; ASPERGILLUS FUMIGATUS; FUNGI; MUS;

EID: 45049083852     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mycmed.2008.02.001     Document Type: Article

References (29)

1. Berliner S., and Aronson M. The phenomenon of leukergy (leukocyte adhesiveness/aggregation): a powerful investigative tool and a sensitive indicator of inflammation, trauma and stress. Isr J Med Sci 27 (1991) 164-172
2. Bisi M., Palou J., Segarra J., Salvador J., and Villavicenco H. Percutaneous treatment of a primary renal aspergilloma in patient with AIDS. Arch Ital Urol Androl 75 (2003) 119-123
3. Bodey G.P., and Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 8 (1989) 413-437
4. Booth C. Fungal culture media. In: Norris J.R., and Ribbons D.W. (Eds). Methods in Microbiology 4 (1971), Academic Press, London & New York 49-94
5. Cenci E., Perito S., Enssle K.H., Mosci P., Latge J.P., Romani L., et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 65 (1997) 564-570
6. Cohen J., and Lynn W.A. Microbiological considerations in sepsis. Sepsis 2 (1998) 101-106
7. Daikos G.L., Syriopoulou V., Aperis G., Toubanakis C., Petrikkos G., and Demonakos M. Disseminated aspergillosis mimicking hepatic veno-occlusive disease. An Intern Med 143 (2005) 315-316
8. Dannaoui E. Animal models for evaluation of antifungal efficacy against filamentous fungi. In: Kavanagh K. (Ed). Medical mycology: cellular and molecular techniques (2006), John Wiley and Sons, Chichester 115-135
9. Dannaoui E., Addo A., Borel E., Piens M.A., Persat F., and Picot S. Invasive aspergillosis associated with prolonged leukopenia in a murine model. J Mycol Med 9 (1999) 221-225
10. De Medeiros C.R., Dantas da Cunha Jr. A., Pasquini R., and Arns da Cunha C. Primary renal aspergillosis: extremly uncommon presentation in patients treated with bone marrow transplantation. Bone Marrow Transplant 24 (1999) 113-114
11. Denning D.W., and Stevens D.A. Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis. Antimicrob Agents Chemother 35 (1991) 1329-1333
12. Denning D.W. Invasive aspergillosis. Clin Infect Dis 26 (1998) 781-805
13. Duong M., Ouellet N., Simard M., Bergeron Y., Olivier M., and Bergeron M.G. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis 178 (1998) 1472-1482
14. Ewing S., Paar W.D., Pakos E., Schafer H., Tasci S., Marklein G., et al. Nosocomial ventilator-associated pneumonias caused by Aspergillus fumigatus in non-immunosuppressed, non-neutropenic patients. Pneumologie 52 (1998) 85-90
15. Kistemann T., Huneburg H., Exner M., Vacata V., and Engelhart S. Role of increased environmental Aspergillus exposure for patients with chronic obstructive pulmonary disease (COPD) treated with corticosteroids in an intensive care unit. Int J Hyg Environ Health 204 (2002) 347-351
16. Latge J.P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12 (1999) 310-350
17. Maharshak N., Kassirer M., Zeltser D., Rotstein R., Rogowski O., Shapira I., et al. The inflammation meter: Novel technology to detect the presence of infection/inflammation in patients without leukocytosis but with increased leukocyte adhesiveness/aggregation. Acta Hematologica 104 (2000) 16-21
18. Park S.B., Kang M.J., Whang E.A., Han S.Y., and Kim H.C. A case of fungal sepsis due to Aspergillus spondylitis followed by cytomegalovirus infection in a renal transplant recipient. Transplant Proc 36 (2004) 2154-2155
19. Raja N.S., and Singh N.N. Disseminated invasive aspergillosis in an apparently immunocompetent host. J Microbiol Immunol Infect 39 (2006) 73-77
20. Shelton B.K. Opportunistic infections in the critically ill. Crit Care Nurs Clin North Am 12 (2000) 323-340
21. Shibuya K., Naoe S., and Yamaguchi H. Animal models of A. fumigatus infections. In: Brakhage A.A., Jahn B., and Schmidt A. (Eds). Contribution to Microbiology 2 (1999), Karger, Basel 130-138
22. Shibuya K., Takaoka M., Uchida K., Wakayama M., Yamaguchi H., Takahashi K., et al. Histopathology of experimental invasive pulmonary aspergillosis in rats: pathological comparison of pulmonary lesions induced by specific virulent factor deficient mutants. Microb Pathog 27 (1999) 123-131
23. Shibuya K., Ando T., Hasegawa C., Wakayama M., Hamatani S., Hatori T., Nagayama T., et al. Pathophysiology of pulmonary aspergillosis. J Infect Chemother 10 (2004) 138-145
24. Sionov E., Mendlovic S., and Segal E. Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF. J Antimicrob Chemo 56 (2005) 594-597
25. Soubani A.O., and Chandrasekar P.H. The clinical spectrum of pulmonary aspergillosis. Chest 121 (2002) 1988-1999
26. Stevens D.A., Kan V.L., Judson M.A., Morrison V.A., Dummer S., Denning D.W., et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 30 (2000) 696-709
27. Stevens D.A. Diagnosis of fungal infections: current status. J Antimic Chemo 49 (2002) 11-19
28. Young R.C., Bennett J.E., Vogel C.L., Carbone P.P., and DeVita V.T. Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 49 (1970) 147-173
29. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanon M.H., et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. EPIC international advisory committee. JAMA 274 (1995) 639-644